Sign inJoin waitlistJoin the waitlist

JA

Joshua Acosta

Credentials:

History

Residency
2020–2023
Medical School
2016–2020

Research

Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial
Nature Medicine · 2026
Evaluation of a Tumor-Informed Molecular Residual Disease Assay in Early Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy, With or Without Atezolizumab
JCO Precision Oncology · 2026

Charles Geyer
2 papers
Christie Hilton
2 papers
EM
Eleftherios Mamounas
2 papers
Norman Wolmark
2 papers
Peter Polewski
2 papers
Priya Rastogi
2 papers
SM
Sujatha Murali
2 papers
Antoinette Tan
1 paper
BA
Bradley Arrick
1 paper
Frederick Baehner
1 paper
JL
Janine Lobello
1 paper
JA
Jay Andersen
1 paper